|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/17/2024 |
$4.15 |
$4.35 |
$4.09 |
$4.28 |
690.10K | 04/18/2024 |
$4.31 |
$4.31 |
$4.04 |
$4.17 |
692.60K | 04/19/2024 |
$4.13 |
$4.30 |
$3.96 |
$4.11 |
733.10K | 04/22/2024 |
$4.15 |
$4.20 |
$3.94 |
$4.10 |
488.20K | 04/23/2024 |
$4.15 |
$4.32 |
$4.10 |
$4.19 |
354.90K |
|
G1 Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer. Co.'s primary compound trilaciclib is a therapy designed to help protect against chemotherapy-induced myelosuppression. Trilaciclib helps protect hematopoietic stem and progenitor cells in the bone marrow by transiently inhibiting CDK4/6 leading to a temporary arrest of susceptible host cells during chemotherapy in patients. Rintodestrant is an oral selective estrogen receptor degrader for the treatment of ER+ breast cancer. | |
|
G1 Therapeutics (GTHX) has the following price history information. Looking back at GTHX historical stock prices for the last five trading days, on April 17, 2024, GTHX opened at $4.15, traded as high as $4.35 and as low as $4.09, and closed at $4.28. Trading volume was a total of 690.10K shares. On April 18, 2024, GTHX opened at $4.31, traded as high as $4.31 and as low as $4.04, and closed at $4.17. Trading volume was a total of 692.60K shares. On April 19, 2024, GTHX opened at $4.13, traded as high as $4.30 and as low as $3.96, and closed at $4.11. Trading volume was a total of 733.10K shares. On April 22, 2024, GTHX opened at $4.15, traded as high as $4.20 and as low as $3.94, and closed at $4.10. Trading volume was a total of 488.20K shares. On April 23, 2024, GTHX opened at $4.15, traded as high as $4.32 and as low as $4.10, and closed at $4.19. Trading volume was a total of 354.90K shares.
GTHX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into G1 Therapeutics shares, starting with a $10,000 purchase of GTHX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/18/2017 |
|
End date: |
04/23/2024 |
|
Start price/share: |
$16.60 |
|
End price/share: |
$4.19 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-74.76% |
|
Average Annual Total Return: |
-18.00% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,524.22 |
|
Years: |
6.94 |
|
|
|
Date |
Close |
04/17/2024 | $4.28 | 04/18/2024 | $4.17 | 04/19/2024 | $4.11 | 04/22/2024 | $4.10 | 04/23/2024 | $4.19 |
|
|